Platelet P2Y12 receptor inhibition by thienopyridines: status and future

By Porto Italo   Giubilato Simona   De Maria Giovanni Luigi   Biasucci Luigi Marzio   Crea Filippo  

Expert Opinion on Investigational Drugs, Vol. 18, Iss. 9, 2009-09 ,pp. : 1317-1332

Informa Healthcare

Access to resources Recommend Favorite

Platelet P2Y 12 Receptor Inhibition: An Update on Clinical Drug Development

By Vivas David   Angiolillo Dominick J.  

American Journal of Cardiovascular Drugs, Vol. 10, Iss. 4, 2010-08 ,pp. : 217-226

Adis International

Access to resources Recommend Favorite

Prasugrel: a novel platelet ADP P2Y₁₂ receptor antagonist. A review on its mechanism of action and clinical development

By Angiolillo Dominick J   Suryadevara Siva   Capranzano Piera   Bass Theodore A  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 16, 2008-11 ,pp. : 2893-2900

Informa Healthcare

Access to resources Recommend Favorite

Pleiotropic Effects of Platelet P2Y₁₂ Receptor Inhibitors: Fact or Fiction?

By  

Current Pharmaceutical Design, Vol. 20, Iss. 28, 2014-08 ,pp. : 4597-4604

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of P2Y₁₂ Receptor and Activated Platelets During Inflammation

By  

Current Drug Targets, Vol. 15, Iss. 7, 2014-06 ,pp. : 720-728

Bentham Science Publishers

Access to resources Recommend Favorite